Apex new generation hepatitis B surface antigen qualitative and confirmatory test set - Taiwan Registration 6d453964a611ae96f5cf31812007b00a

Access comprehensive regulatory information for Apex new generation hepatitis B surface antigen qualitative and confirmatory test set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 6d453964a611ae96f5cf31812007b00a and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.